Form D Explorer

Form D — Kestrel Therapeutics Inc.

0001853373-25-000001 · filed Feb 21, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
06b
Reported offering amount
$16,000,000
Reported amount sold
$8,000,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Kestrel Therapeutics Inc.
CIK
1853373
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2020
Address
Attn: Pagliuca Harvard Life Lab
Boston, MA 02134
Phone
617-460-3772

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗